Therapy with oral directly acting agents in hepatitis C infection is associated with reduction in fibrosis and increase in hepatic steatosis

被引：0
|
作者：
Shalimar [1 ]
Rout, G. [1 ]
Gupta, S. [1 ]
Gunjan, D. [1 ]
Kedia, S. [1 ]
Nayak, B. [1 ]
机构：
[1] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)31323-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-383
引用
收藏
页码：S535 / S535
页数：1
相关论文
共 50 条
  • [1] Efficacy of Generic Oral Directly Acting Agents in Patients with Hepatitis C Virus Infection
    Gupta, Swatantra
    Rout, Shalimar Gyanranjan
    Sethia, Rahul
    Jadaun, Shekhar S.
    Agarwal, Ashish
    Iqbal, Asif
    Gunjan, Deepak
    Kedia, Saurabh
    Nayak, Baibaswata
    Ranjan, Gyan
    HEPATOLOGY, 2017, 66 : 618A - 618A
  • [2] Efficacy of generic oral directly acting agents in patients with hepatitis C virus infection
    Gupta, S.
    Rout, G.
    Patel, A. H.
    Mahanta, M.
    Kalra, N.
    Sahu, P.
    Sethia, R.
    Agarwal, A.
    Ranjan, G.
    Kedia, S.
    Acharya, S. K.
    Nayak, B.
    Shalimar
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (07) : 771 - 778
  • [3] Hepatitis C infection and hepatic steatosis: Fibrosis is not forged in the flame of fat
    Perumalswami, P
    Kleiner, D
    Lutchman, G
    Heller, T
    Bozorg, B
    Park, Y
    Liang, TJ
    Ghany, M
    Hoofnagle, J
    GASTROENTEROLOGY, 2004, 126 (04) : A672 - A672
  • [4] Hepatic steatosis in patients with chronic hepatitis C is associated with HCV genotype and BMI but is not associated with advanced hepatic fibrosis or response to therapy
    Qadri, A
    Barnes, D
    Carey, W
    Edwards, K
    Zein, N
    GASTROENTEROLOGY, 2004, 126 (04) : A697 - A697
  • [5] Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan
    Hsieh, Meng-Hsuan
    Lee, Li-Po
    Hsieh, Ming-Yen
    Tsai, Kun-Bow
    Huang, Jee-Fu
    Hou, Nai-Jen
    Chen, Shinn-Chern
    Lin, Zu-Yau
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2007, 60 (06) : 377 - 381
  • [6] THE GRADE OF HEPATITIS C RELATED HEPATIC FIBROSIS AND STEATOSIS
    Iqbal, Tahir
    Fayyaz, Fand
    Ashiq, Muhammad Asif
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (11): : 11112 - 11117
  • [7] Nutritional status and hepatic steatosis after direct-acting antiviral therapy for chronic hepatitis C virus infection
    Shimada, Masaaki
    Iwase, Hiroaki
    Hirashima, Noboru
    Ryuge, Nobumitsu
    Urata, Noboru
    Umeshita, Jin
    Unita, Satoshi
    Kondo, Takashi
    Tanaka, Daiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 155 - 155
  • [8] The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis
    Magri, Mariana Cavalheiro
    Manchiero, Caroline
    Gago Prata, Thamiris Vaz
    da Silva Nunes, Arielle Karen
    de Oliveira Junior, Jose Santos
    Dantas, Bianca Peixoto
    Tengan, Fatima Mitiko
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 97 (02)
  • [9] Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: Is it associated with antiretroviral therapy and more advanced hepatic fibrosis?
    Verma S.
    Goldin R.D.
    Main J.
    BMC Research Notes, 1 (1)
  • [10] EVALUATING HEPATITIS B REACTIVATION IN PATIENTS TREATED WITH DAA (DIRECTLY ACTING ANTIVIRAL AGENTS) FOR HEPATITIS C INFECTION
    Mubarak, Abdullah
    Keng, Caleb
    Talati, Tapan
    Kakadia, Avani
    HEPATOLOGY, 2020, 72 : 557A - 558A
12345